Florbetaben F-18 Patent Expiration
Florbetaben F-18 is Used for estimating p-amyloid neuritic plaque density in adult patients with cognitive impairment through PET imaging of the brain. It was first introduced by Life Molecular Imaging Ltd
Florbetaben F-18 Patents
Given below is the list of patents protecting Florbetaben F-18, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Neuraceq | US7807135 | Stilbene derivatives and their use for binding and imaging amyloid plaques | Mar 18, 2029 | Life Molecular |
| Neuraceq | US7907135 | Image display and image displaying method for gradation correction | Mar 18, 2029 | Life Molecular |
Florbetaben F-18's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List